Polyethylene Glycol Excipient Excipient Use in Intravenous Dosage Forms

Polyethylene Glycol Excipient

DESCRIPTION

DESCRIPTION

Suppliers

17 Listed Products, 2 Nomisma Healthcare, 3 Actylis, 2 Seqens, 1 Gangwal Chemicals, 8 BASF, 1 Finar

REGULATORY FILINGS

5 Suppliers, 4 USDMF, 1 JDMF

SOLUTIONS BY APPLICATIONS

7 Topical, 4 Thickeners and Stabilizers, 4 Controlled & Modified Release, 4 Solubilizers, 2 Parenteral, 1 Film Formers & Plasticizers, 1 Granulation, 1 Coating Systems & Additives

ANALYTICAL SOLUTION(s)

10 Other Ref. Standards

10 Other Ref. Standards

FINISHED FORMULATIONS

1087 ORAL, 760 TABLET, 186 TABLET, EXTENDED RELEASE, 56 CAPSULE, 24 CAPSULE, EXTENDED RELEASE, 21 TABLET, DELAYED RELEASE, 11 CAPSULE, DELAYED REL PELLETS, 11 TOPICAL, 10 ORAL-28, 9 OINTMENT, 9 SOLUTION, 8 FOR SUSPENSION, 5 CAPSULE, DELAYED RELEASE, 4 FILM, 4 TABLET, CHEWABLE, 3 BUCCAL, SUBLINGUAL, 3 SUSPENSION, 3 TABLET, ORALLY DISINTEGRATING, 2 EMULSION, 2 GRANULE, 2 INTRAVENOUS, 2 ORAL-21, 2 TABLET, ORALLY DISINTEGRATING, EXTENDED RELEASE, 2 VAGINAL, 1 CAPSULE, TABLET, CAPSULE, DELAYED REL PELLETS, 1 CONCENTRATE, 1 CREAM, 1 FOR SOLUTION, 1 FOR SUSPENSION, DELAYED RELEASE, 1 IM-IV, 1 INJECTABLE, 1 INJECTION, 1 INSERT, EXTENDED RELEASE, 1 SUSPENSION, EXTENDED RELEASE, 1 SYRUP, 1 TABLET, COATED PARTICLES